Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
McKinsey
Harvard Business School
Johnson and Johnson
Moodys

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PINDOLOL

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Pindolol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00007592 Hypertension Screening and Treatment Program Completed VA Office of Research and Development N/A 1989-06-01 Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
NCT00149110 Chronos: the Use of Chronobiological Treatment in Depression Completed Eli Lilly and Company N/A 2005-09-01 The primary objective of the present study is to examine whether the combination of the antidepressant duloxetine and chronotherapeutic methods (including sleep deprivation, light therapy, and maintaining a regular sleep-wake rhythm) in patient with major depression, will induce an immediate improvement from depression and whether this antidepressive effect will be maintained in the long term (29 weeks). Patient will be randomised to the above mentioned treatment or to an active group receiving exercise.
NCT00149110 Chronos: the Use of Chronobiological Treatment in Depression Completed The County of Frederiksborg N/A 2005-09-01 The primary objective of the present study is to examine whether the combination of the antidepressant duloxetine and chronotherapeutic methods (including sleep deprivation, light therapy, and maintaining a regular sleep-wake rhythm) in patient with major depression, will induce an immediate improvement from depression and whether this antidepressive effect will be maintained in the long term (29 weeks). Patient will be randomised to the above mentioned treatment or to an active group receiving exercise.
NCT00149110 Chronos: the Use of Chronobiological Treatment in Depression Completed Hillerod Hospital, Denmark N/A 2005-09-01 The primary objective of the present study is to examine whether the combination of the antidepressant duloxetine and chronotherapeutic methods (including sleep deprivation, light therapy, and maintaining a regular sleep-wake rhythm) in patient with major depression, will induce an immediate improvement from depression and whether this antidepressive effect will be maintained in the long term (29 weeks). Patient will be randomised to the above mentioned treatment or to an active group receiving exercise.
NCT00159146 Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression Terminated Tvergaards Foundation N/A 2002-08-01 This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.
NCT00159146 Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression Terminated Wyeth is now a wholly owned subsidiary of Pfizer N/A 2002-08-01 This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.
NCT00159146 Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression Terminated Hillerod Hospital, Denmark N/A 2002-08-01 This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pindolol

Condition Name

Condition Name for Pindolol
Intervention Trials
Major Depression 3
Healthy 2
Hypertension 1
Unipolar Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pindolol
Intervention Trials
Depression 6
Depressive Disorder 6
Depressive Disorder, Major 4
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pindolol

Trials by Country

Trials by Country for Pindolol
Location Trials
United States 14
Denmark 3
Switzerland 2
Spain 2
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pindolol
Location Trials
Florida 2
California 2
Mississippi 1
Iowa 1
Indiana 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pindolol

Clinical Trial Phase

Clinical Trial Phase for Pindolol
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
Phase 2 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pindolol
Clinical Trial Phase Trials
Completed 5
Terminated 3
Withdrawn 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pindolol

Sponsor Name

Sponsor Name for Pindolol
Sponsor Trials
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2
Hillerod Hospital, Denmark 2
University Hospital, Basel, Switzerland 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pindolol
Sponsor Trials
Other 19
Industry 4
NIH 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
McKesson
Colorcon
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.